DTE

30.68

-3.61%↓

IBE

20.35

+0.99%↑

RWE

59

+0.82%↑

ELE

37.41

+1.52%↑

FORTUM.FI

22.5

+4.8%↑

DTE

30.68

-3.61%↓

IBE

20.35

+0.99%↑

RWE

59

+0.82%↑

ELE

37.41

+1.52%↑

FORTUM.FI

22.5

+4.8%↑

DTE

30.68

-3.61%↓

IBE

20.35

+0.99%↑

RWE

59

+0.82%↑

ELE

37.41

+1.52%↑

FORTUM.FI

22.5

+4.8%↑

DTE

30.68

-3.61%↓

IBE

20.35

+0.99%↑

RWE

59

+0.82%↑

ELE

37.41

+1.52%↑

FORTUM.FI

22.5

+4.8%↑

DTE

30.68

-3.61%↓

IBE

20.35

+0.99%↑

RWE

59

+0.82%↑

ELE

37.41

+1.52%↑

FORTUM.FI

22.5

+4.8%↑

Search

Grenergy Renovables SA

Suletud

118.6 0.85

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

118.6

Max

119.2

Põhinäitajad

By Trading Economics

Sissetulek

7.7M

10M

Müük

307M

383M

Aktsiakasum

1.483

Kasumimarginaal

13.72

EBITDA

59M

91M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

-9.66% downside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

21. mai 2026

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

Grenergy Renovables SA Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

6. apr 2026, 23:17 UTC

Tulu

Samsung Forecasts Record First-Quarter Operating Profit

6. apr 2026, 23:00 UTC

Kuumad aktsiad

Stocks to Watch: Health Insurers, Mawson, Owlet

6. apr 2026, 22:13 UTC

Suurimad hinnamuutused turgudel

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6. apr 2026, 21:46 UTC

Omandamised, ülevõtmised, äriostud

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6. apr 2026, 17:09 UTC

Suurimad hinnamuutused turgudel

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6. apr 2026, 16:56 UTC

Uudisväärsed sündmused

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6. apr 2026, 14:47 UTC

Suurimad hinnamuutused turgudel

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7. apr 2026, 00:00 UTC

Uudisväärsed sündmused

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6. apr 2026, 23:58 UTC

Market Talk
Uudisväärsed sündmused

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6. apr 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6. apr 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6. apr 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6. apr 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6. apr 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6. apr 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6. apr 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6. apr 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6. apr 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6. apr 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6. apr 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6. apr 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6. apr 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6. apr 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6. apr 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6. apr 2026, 18:36 UTC

Omandamised, ülevõtmised, äriostud

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. apr 2026, 17:59 UTC

Market Talk
Uudisväärsed sündmused

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6. apr 2026, 17:13 UTC

Omandamised, ülevõtmised, äriostud

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. apr 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6. apr 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6. apr 2026, 14:59 UTC

Tulu

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Võrdlus sarnastega

Hinnamuutus

Grenergy Renovables SA Prognoos

Hinnasiht

By TipRanks

-9.66% langus

12 kuu keskmine prognoos

Keskmine 107.5 EUR  -9.66%

Kõrge 115 EUR

Madal 100 EUR

Põhineb 2 Wall Streeti analüütiku instrumendi Grenergy Renovables SA 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

2

Osta

0

Hoia

0

Müü

Tehniline skoor

By Trading Central

50.8 / 52.4Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Keskpikk perspektiiv

Bullish Evidence

Pikk perspektiiv

Bullish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Grenergy Renovables SA

Grenergy Renovables, S.A., together with its subsidiaries, operates as an independent power producer. It operates through Development and Construction, Energy, Commercialization, and Services divisions. The company designs, develops, constructs, and operates photovoltaic and wind energy projects. Its activities include promotion, commercialization, and construction of renewable energy installations; production and commercialization of electric energy; management and operation of renewable energy installations; and asset management services. It has operations in Spain, Chile, Mexico, the United Kingdom, the Unites States, Poland, Germany, Peru, Colombia, Romania, Argentina, and Italy. Grenergy Renovables, S.A. was incorporated in 2007 and is based in Madrid, Spain. Grenergy Renovables, S.A. operates as a subsidiary of Daruan Group Holding, S.L.
help-icon Live chat